Clinical Trial Update: A Clinical Study in AGHD to Assess Safety, Tolerability and Efficacy of GX-H9 [Phase 2]

View source ↗

Summary

A Phase 2 clinical study evaluating GX-H9 for safety, tolerability, and efficacy in adults with growth hormone deficiency has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• GX-H9 (GX-H9)

Snippet

Sponsor: Genexine, Inc. | Conditions: Adult Growth Hormone Deficiency | Phase 2 | Status: COMPLETED